Stay updated with breaking news from Clinical Development Highlights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory
Relief Therapeutics Holding SA / Key word(s): Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant
Investegate announcements from Relief Therapeutics Holding SA, Relief Reports Half-Year 2022 Results and Provides Corporate Update
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address
(2022-05-26 | NYSEAM:CANF) Can-Fite Reports First Quarter 2022 Financial Results & Provides Clinical Update